Studies in Porphyria IV: Gonadotropin-Releasing Hormone (GnRH) Analogues for Prevention of Cyclic Attacks
NCT00004330 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL
Last updated 2005-06-24
Summary
OBJECTIVES:
Assess whether chronic administration of gonadotropin-releasing hormone analogues is safe and effective for the prevention of cyclic attacks of acute porphyria in women.
Conditions
- Porphyria
Interventions
- DRUG
-
luteinizing hormone-releasing factor
Sponsors & Collaborators
-
University of Texas
collaborator OTHER -
National Center for Research Resources (NCRR)
lead NIH
Principal Investigators
-
Karl E Anderson · University of Texas
Study Design
- Purpose
- PREVENTION
Eligibility
- Min Age
- 18 Years
- Max Age
- 55 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 1987-03-31
Countries
- United States
Study Locations
More Related Trials
-
Octreotide Therapy in Children and Young Adults With Prader-Willi Syndrome (PWS)
NCT00399893 ·Status: TERMINATED ·Phase: NA
-
Efficacy of Pulsatile GnRH Therapy on Male Patients With Pituitary Stalk Interruption Syndrome
NCT02705014 ·Status: UNKNOWN ·Phase: NA
-
Study of the Effect of Growth Hormone-Releasing Hormone Antagonist on Growth Hormone Release in Acromegaly
NCT00004332 ·Status: COMPLETED
-
The Glucagon Stimulation Test for Evaluation of Adult Growth Hormone Deficiency and Adrenocorticotropic Axis
NCT01282164 ·Status: COMPLETED ·Phase: NA
-
An Assessment of the Occurrence of Hormone Deficiency in Patients With Empty Sella
NCT04700020 ·Status: UNKNOWN ·Phase: NA
-
Studying the Effects of 7 Days of Gonadotropin Releasing Hormone (GnRH) Treatment in Men With Hypogonadism
NCT00493961 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Assess the Efficacy and Safety of Eutropin in Prader-Willi Syndrome
NCT02204163 ·Status: COMPLETED ·Phase: PHASE3
-
Histrelin Subcutaneous Implant in Children With Central Precocious Puberty
NCT00779103 ·Status: COMPLETED ·Phase: PHASE3
-
Anterior Pituitary Hormone Replacement in Traumatic Brain Injury
NCT00957671 ·Status: COMPLETED ·Phase: PHASE4
-
Mass Spectrometry Based Cutoffs for Cortisol After Stimulation Tests
NCT02818660 ·Status: COMPLETED ·Phase: NA
-
Examination of Idiopathic Hypogonadotropic Hypogonadism (IHH)and Kallmann Syndrome (KS)
NCT00392756 ·Status: COMPLETED ·Phase: PHASE1
-
Elucidation of the Effects of Growth Hormone (GH) Deficiency and GH Replacement on Clot and Platelet
NCT02049671 ·Status: UNKNOWN
-
Ghrelin in Healthy and Frail Older Women
NCT00520884 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Study of an Extended-Release, Crystalline Formulation of Recombinant Human Growth Hormone (ALTU-238) in Growth Hormone Deficient Adults to Determine Pharmacokinetics, Pharmacodynamics, and Drug Safety
NCT00297713 ·Status: COMPLETED ·Phase: PHASE2
-
Long-term Outcome of GnRH Analogues Treatment of Children With Idiopathic Central Precocious Puberty
NCT02790112 ·Status: UNKNOWN ·Phase: NA
-
Comparisons of Different Forms of Glucocorticoid on the Recovery of Reproductive Function in Patients With 21α-hydroxylase Deficiency
NCT04536662 ·Status: UNKNOWN ·Phase: PHASE4
-
Administration of Kisspeptin in Patients With Hyperprolactinemia
NCT02956447 ·Status: COMPLETED ·Phase: PHASE2
-
Growth Hormone and Endothelial Function in Children
NCT00373386 ·Status: COMPLETED ·Phase: PHASE4
-
The IGFBP-3 Stimulation Test: A New Tool for the Diagnosis of Growth Hormone Deficiency in Children.
NCT00235599 ·Status: COMPLETED
-
Endocrine Studies of Healthy Children
NCT00001195 ·Status: COMPLETED
-
Reproducibility and Utility of OGTT in Acromegaly
NCT04066569 ·Status: COMPLETED ·Phase: NA
-
A GnRH Agonist IN Pre-menopausal Women STudy to Treat Severe Polycystic Liver Disease
NCT05478083 ·Status: RECRUITING ·Phase: PHASE2
-
Sexually Dimorphic Effects of GHRH in Adult Growth Hormone Testing
NCT00324064 ·Status: COMPLETED ·Phase: NA
-
Effects of GH and Lirglutide on AgRP
NCT05681299 ·Status: RECRUITING ·Phase: PHASE4
-
Efficacy and Safety of Pulsatile Gonadotropin Releasing Hormone Pump Treatment in Patients With Idiopathic Hypogonadotropic Hypogonadism
NCT02310074 ·Status: UNKNOWN ·Phase: PHASE4